Edition:
United Kingdom

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

6.41USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$6.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
221,136
52-wk High
$13.30
52-wk Low
$5.02

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.36 -0.595
Mar '18 0.15 -0.683
FY 2017 Dec '17
Sep '17 0.13 -0.706
Jun '17 0.00 -0.739
Mar '17 0.13 -0.805
FY 2016 Dec '16 0.08 -0.737
Sep '16 0.11 -0.657
Jun '16 0.10 -0.613
Mar '16 0.09 -0.561
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.11 0.40 0.00 0.05
Quarter Ending Dec-18 5 1.19 5.43 0.00 0.05
Year Ending Dec-18 5 1.75 5.95 0.50 0.68
Year Ending Dec-19 5 2.86 10.80 0.00 18.09
Earnings (per share)
Quarter Ending Sep-18 5 -0.58 -0.55 -0.64 -0.72
Quarter Ending Dec-18 5 -0.59 -0.43 -0.76 -0.72
Year Ending Dec-18 5 -2.44 -2.26 -2.68 -2.94
Year Ending Dec-19 5 -2.43 -2.03 -3.27 -2.82
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.64 45.45
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 1,169.61 114.98 5.75
Price to Book (MRQ) 3.08 15.51 5.47
Price to Tangible Book (MRQ) 3.08 14.52 7.04
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 57.02 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 13.73 80.50 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -20.53 29.15 20.61
EPS (TTM) vs TTM 1 Yr. Ago -26.74 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 8.34 5.53 3.03
LT Debt to Equity (MRQ) 22.22 35.26 12.51
Total Debt to Equity (MRQ) 25.02 37.08 16.85
Interest Coverage (TTM) -- -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -24,512.38 -- --
EBITD - 5 Yr. Avg -- -603.21 10.65
Operating Margin (TTM) -25,442.11 -759.76 4.33
Operating Margin - 5 Yr. Avg. -- -625.13 6.06
Pre-Tax Margin (TTM) -26,033.13 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -628.46 6.49
Net Profit Margin (TTM) -26,033.13 -734.98 1.48
Net Profit Margin - 5 Yr. Avg. -- -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,936 23,229,989 860,433,555
Net Income/Employee (TTM) -764,427 3,144,143 101,214,060
Receivable Turnover (TTM) 0.98 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.94 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.50 12.40
Return on Investment (TTM) -56.99 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.55 16.13
Return on Equity (TTM) -67.22 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.42 17.39
  1 Year 3 Year 5 Year
Sales % 37.59 -41.53 --
EPS (TTM) % -39.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellicum Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.25 9.34 99 53
13 Week -2.82 -7.55 89 66
26 Week -6.65 -13.75 89 80
52 Week -43.96 -52.50 40 50
YTD -16.52 -26.69 59 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.62%
# of Holders: 147
Total Shares Held: 21,510,877
3 Mo. Net Change: 2,479,379
# New Positions: 10
# Closed Positions: 1
# Increased Positions: 41
# Reduced Positions: 7
# Net Buyers: 34
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.